John Dwyer, the President of the Global Alzheimer’s Platform Foundation (GAP) joins TrialSiteNews to discuss a collaboration and partnership with Circular Genomics. The partnership will analyze blood test samples to investigate the potential for circular RNA biomarkers to assist in the diagnosis & treatment of Alzheimer’s Disease. Topics covered:
- The gap circular RNA technology can fill
- What makes this dataset uniquely important?
- Could this speed up Alzheimer’s detection?
- What ‘precision medicine for Alzheimer’s’ actually means
- Goal for this collaboration with Circular Genomics
- How Alzheimer’s diagnosis and treatment will look five years from now
Press Release: https://globalalzplatform.org/2026/05…